You are viewing the site in preview mode

Skip to main content

Advertisement

Contact Hiroyoshi Nishikawa

From: Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment

Contact corresponding author